Cargando…
MON-603 Racial Distribution of Endocrine Complications in Oncology Patients Treated with Immune Checkpoint Inhibitors
Background: Immune-related adverse events (irAEs) have been frequently described with the growing use of immune checkpoint inhibitors (ICI) in cancer treatment. While many autoimmune diseases are known to be more prevalent in certain racial groups, it is unknown if there are racial disparities in th...
Autores principales: | Brooks, Danielle, Leiter, Amanda, Carroll, Emily, Ben Shimol, Jennifer, Eisenberg, Elliot, Galsky, Matthew, Gallagher, Emily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550805/ http://dx.doi.org/10.1210/js.2019-MON-603 |
Ejemplares similares
-
SAT-411 Vitamin D Levels and Risk of Thyroid Immune Related Adverse Events in Patients on Immune Checkpoint Inhibitors
por: Newman, Samantha Kass, et al.
Publicado: (2020) -
SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy
por: Leiter, Amanda, et al.
Publicado: (2019) -
FRI539 Vitamin D and Endocrine Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
por: He, Zijun, et al.
Publicado: (2023) -
SAT-603 Graves' Disease and an Anterior Mediastinal Mass
por: Robbins, D'lorah, et al.
Publicado: (2019) -
SUN-603 A Case of Papillary Thyroid Cancer and EXTRAOVARIAN Pelvic Teratoma
por: Yeasmin, Shamima, et al.
Publicado: (2019)